Abbott Financial Statements From 2010 to 2024

ABT Stock  USD 105.27  0.63  0.59%   
Abbott Laboratories financial statements provide useful quarterly and yearly information to potential Abbott Laboratories investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Abbott Laboratories financial statements helps investors assess Abbott Laboratories' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Abbott Laboratories' valuation are summarized below:
Gross Profit
24.6 B
Profit Margin
0.1427
Market Capitalization
189.5 B
Enterprise Value Revenue
4.9284
Revenue
40.1 B
There are currently one hundred twenty fundamental signals for Abbott Laboratories that can be evaluated and compared over time across rivals. All traders should validate Abbott Laboratories' prevailing fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 236.1 B in 2024. Enterprise Value is likely to gain to about 244.8 B in 2024

Abbott Laboratories Total Revenue

22.16 Billion

Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.4 B, Interest Expense of 605.1 M or Selling General Administrative of 6.2 B, as well as many exotic indicators such as Price To Sales Ratio of 5.01, Dividend Yield of 0.0176 or PTB Ratio of 2.62. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
  
This module can also supplement Abbott Laboratories' financial leverage analysis and stock options assessment as well as various Abbott Laboratories Technical models . Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.

Abbott Laboratories Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets36.9 B73.2 B56.8 B
Slightly volatile
Short and Long Term Debt Total9.8 B15.9 B15.4 B
Slightly volatile
Other Current Liabilities8.1 B7.7 B6.3 B
Slightly volatile
Total Current Liabilities8.3 B13.8 B10.5 B
Slightly volatile
Total Stockholder Equity40.5 B38.6 B27.9 B
Slightly volatile
Property Plant And Equipment Net6.2 B11.3 B7.2 B
Slightly volatile
Net Debt6.1 BB8.5 B
Slightly volatile
Retained Earnings39.4 B37.6 B25.9 B
Slightly volatile
Cash3.7 B6.9 B6.9 B
Pretty Stable
Non Current Assets Total53.1 B50.5 B39.6 B
Slightly volatile
Non Currrent Assets Other3.1 BB5.8 B
Pretty Stable
Cash And Short Term Investments4.3 B7.3 B7.9 B
Very volatile
Net Receivables3.9 B6.6 B5.2 B
Slightly volatile
Common Stock Shares Outstanding1.3 B1.7 B1.7 B
Very volatile
Liabilities And Stockholders Equity36.9 B73.2 B56.8 B
Slightly volatile
Non Current Liabilities Total11.7 B20.5 B19.9 B
Slightly volatile
Inventory6.9 B6.6 BB
Slightly volatile
Other Current Assets2.2 B2.3 B2.6 B
Slightly volatile
Total Liabilities20 B34.4 B30.4 B
Slightly volatile
Property Plant And Equipment Gross23 B21.9 B10.5 B
Slightly volatile
Total Current Assets13.3 B22.7 B19.2 B
Pretty Stable
Short Term DebtB1.3 B1.8 B
Slightly volatile
Accounts Payable4.5 B4.3 B2.6 B
Slightly volatile
Current Deferred Revenue420.7 M442.8 M440.8 M
Pretty Stable
Common Stock Total Equity29.8 B28.4 B18.3 B
Slightly volatile
Short Term Investments757.2 M383 M996.4 M
Slightly volatile
Common Stock23.6 B24.9 B671.5 B
Slightly volatile
Intangible Assets9.1 B8.8 B10.3 B
Slightly volatile
Other Liabilities5.7 B7.6 B6.5 B
Slightly volatile
Other Assets5.9 B5.7 B3.3 B
Slightly volatile
Long Term Debt12 B13.6 B13.6 B
Slightly volatile
Property Plant Equipment7.7 B10.5 B7.5 B
Slightly volatile
Good Will15.5 B23.7 B16.8 B
Slightly volatile
Noncontrolling Interest In Consolidated Entity163.8 M251.8 M160.8 M
Slightly volatile
Retained Earnings Total Equity27.2 B40.5 B26.3 B
Slightly volatile
Long Term Debt Total15.8 B16.7 B14.7 B
Slightly volatile
Long Term Investments1.1 B799 M1.1 B
Very volatile
Non Current Liabilities Other4.3 B3.5 B5.2 B
Slightly volatile
Short and Long Term Debt986.8 M1.1 B797.2 M
Slightly volatile
Cash And Equivalents7.1 B8.9 B12.7 B
Slightly volatile
Net Invested Capital42.3 B53.3 B55 B
Slightly volatile
Net Working Capital9.4 B8.8 B9.9 B
Slightly volatile
Capital Stock26.7 B24.9 B24 B
Slightly volatile
Capital Lease Obligations991.1 M949 M819.4 M
Slightly volatile

Abbott Laboratories Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization3.4 B3.2 B1.9 B
Slightly volatile
Selling General Administrative6.2 B11.2 B8.7 B
Slightly volatile
Total Revenue22.2 B40.1 B29.3 B
Slightly volatile
Gross Profit12.5 B22.1 B16.7 B
Slightly volatile
Other Operating Expenses18.2 B33.6 B24.7 B
Slightly volatile
Operating Income3.8 B6.5 B4.5 B
Slightly volatile
EBIT3.7 B7.3 B4.3 B
Slightly volatile
EBITDA11.1 B10.6 B6.4 B
Slightly volatile
Cost Of Revenue9.6 B18 B12.5 B
Slightly volatile
Total Operating Expenses8.6 B15.7 B12.2 B
Slightly volatile
Income Before Tax3.8 B6.7 B4.2 B
Slightly volatile
Net Income3.1 B5.7 B3.7 B
Slightly volatile
Income Tax Expense792.1 M941 M694.1 M
Slightly volatile
Research Development2.3 B2.7 B2.4 B
Very volatile
Net Income Applicable To Common Shares8.4 BB4.4 B
Slightly volatile
Minority Interest264.4 M251.8 M142.4 M
Slightly volatile
Selling And Marketing Expenses476.3 K569.2 K493.6 K
Pretty Stable
Net Income From Continuing Ops4.3 B5.2 B3.9 B
Pretty Stable
Non Recurring397 M331.2 M315.9 M
Very volatile
Discontinued Operations20.5 M21.6 M351 M
Slightly volatile
Tax Provision949.8 MB773.7 M
Slightly volatile
Interest Income269 M384 M176.3 M
Slightly volatile
Reconciled Depreciation2.3 B3.2 B2.9 B
Slightly volatile

Abbott Laboratories Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash FlowB5.1 B4.6 B
Slightly volatile
Begin Period Cash Flow10.4 B9.9 B7.1 B
Slightly volatile
Depreciation1.8 B3.2 B2.4 B
Slightly volatile
Capital Expenditures1.2 B2.2 B1.4 B
Slightly volatile
Total Cash From Operating Activities5.2 B7.3 B6.1 B
Slightly volatile
Net Income3.3 B5.7 B3.6 B
Slightly volatile
End Period Cash FlowB6.9 B6.9 B
Pretty Stable
Stock Based Compensation356.5 M644 M414.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio5.014.7753.5743
Slightly volatile
Dividend Yield0.01760.01860.0261
Slightly volatile
PTB Ratio2.624.96133.6613
Slightly volatile
Days Sales Outstanding50.2759.742863.5364
Slightly volatile
Book Value Per Share23.2922.185616.6767
Slightly volatile
Free Cash Flow Yield0.02510.02640.053
Slightly volatile
Invested Capital0.410.38660.5588
Very volatile
Operating Cash Flow Per Share2.334.1733.5701
Pretty Stable
Stock Based Compensation To Revenue0.00820.01610.0128
Slightly volatile
PB Ratio2.624.96133.6613
Slightly volatile
EV To Sales5.254.99883.8462
Slightly volatile
Free Cash Flow Per Share1.792.90752.7125
Pretty Stable
ROIC0.190.10390.1042
Very volatile
Inventory Turnover3.982.73593.5047
Slightly volatile
Net Income Per Share3.453.28912.3398
Slightly volatile
Days Of Inventory On Hand81.82133105
Slightly volatile
Payables Turnover5.264.18516.2659
Slightly volatile
Sales General And Administrative To Revenue0.220.290.309
Slightly volatile
Research And Ddevelopement To Revenue0.09760.06830.0804
Slightly volatile
Cash Per Share4.394.18334.9648
Very volatile
POCF Ratio27.726.376818.5856
Slightly volatile
Interest Coverage9.6610.169525.4715
Slightly volatile
Payout Ratio0.490.62140.7866
Very volatile
PFCF Ratio39.7537.857626.2169
Slightly volatile
Days Payables Outstanding48.9887.214263.9557
Slightly volatile
Income Quality1.471.27362.3369
Very volatile
ROE0.260.14830.1529
Very volatile
EV To Operating Cash Flow28.9927.613119.9804
Slightly volatile
PE Ratio17.2533.465339.5934
Pretty Stable
Return On Tangible Assets0.170.14050.1223
Slightly volatile
EV To Free Cash Flow41.6139.632128.1418
Slightly volatile
Earnings Yield0.02840.02990.0483
Slightly volatile
Intangibles To Total Assets0.290.44380.416
Slightly volatile
Net Debt To EBITDA0.810.84811.3811
Very volatile
Current Ratio1.241.63791.8973
Pretty Stable
Receivables Turnover6.456.10955.7525
Slightly volatile
Graham Number42.5540.519528.7587
Slightly volatile
Shareholders Equity Per Share23.2922.185616.6767
Slightly volatile
Debt To Equity0.410.38660.5588
Very volatile
Revenue Per Share24.223.051118.3
Slightly volatile
Interest Debt Per Share7.588.94319.5237
Slightly volatile
Debt To Assets0.180.20380.2522
Very volatile
Enterprise Value Over EBITDA19.8918.941818.881
Slightly volatile
Short Term Coverage Ratios3.75.488.0464
Slightly volatile
Price Earnings Ratio17.2533.465339.5934
Pretty Stable
Operating Cycle132193169
Pretty Stable
Price Book Value Ratio2.624.96133.6613
Slightly volatile
Days Of Payables Outstanding48.9887.214263.9557
Slightly volatile
Dividend Payout Ratio0.490.62140.7866
Very volatile
Price To Operating Cash Flows Ratio27.726.376818.5856
Slightly volatile
Price To Free Cash Flows Ratio39.7537.857626.2169
Slightly volatile
Pretax Profit Margin0.210.16610.1443
Pretty Stable
Ebt Per Ebit1.091.02870.9397
Pretty Stable
Operating Profit Margin0.210.16150.1567
Pretty Stable
Effective Tax Rate0.260.14120.2133
Very volatile
Company Equity Multiplier1.731.89662.1194
Pretty Stable
Long Term Debt To Capitalization0.180.26050.3041
Very volatile
Total Debt To Capitalization0.260.27880.3447
Very volatile
Return On Capital Employed0.10.10910.1079
Slightly volatile
Debt Equity Ratio0.410.38660.5588
Very volatile
Ebit Per Revenue0.210.16150.1567
Pretty Stable
Quick Ratio0.721.00021.2885
Pretty Stable
Net Income Per E B T0.630.85880.8582
Pretty Stable
Cash Ratio0.30.49820.6997
Very volatile
Cash Conversion Cycle121106111
Slightly volatile
Operating Cash Flow Sales Ratio0.230.1810.1987
Slightly volatile
Days Of Inventory Outstanding81.82133105
Slightly volatile
Days Of Sales Outstanding50.2759.742863.5364
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.550.69670.7065
Pretty Stable
Cash Flow Coverage Ratios0.920.48650.5589
Slightly volatile
Price To Book Ratio2.624.96133.6613
Slightly volatile
Fixed Asset Turnover2.643.5573.8585
Very volatile
Price Cash Flow Ratio27.726.376818.5856
Slightly volatile
Enterprise Value Multiple19.8918.941818.881
Slightly volatile
Debt Ratio0.180.20380.2522
Very volatile
Cash Flow To Debt Ratio0.920.48650.5589
Slightly volatile
Price Sales Ratio5.014.7753.5743
Slightly volatile
Return On Assets0.120.07820.0729
Very volatile
Asset Turnover0.840.54780.5603
Pretty Stable
Net Profit Margin0.150.14270.1254
Very volatile
Gross Profit Margin0.620.55180.5717
Pretty Stable
Price Fair Value2.624.96133.6613
Slightly volatile
Return On Equity0.260.14830.1529
Very volatile

Abbott Laboratories Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap236.1 B224.8 B135.5 B
Slightly volatile
Enterprise Value244.8 B233.1 B143.6 B
Slightly volatile

Abbott Fundamental Market Drivers

Forward Price Earnings23.6407
Cash And Short Term Investments7.3 B

Abbott Upcoming Events

17th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
22nd of January 2025
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
31st of December 2023
Last Financial Announcement
View

About Abbott Laboratories Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Abbott Laboratories income statement, its balance sheet, and the statement of cash flows. Abbott Laboratories investors use historical funamental indicators, such as Abbott Laboratories's revenue or net income, to determine how well the company is positioned to perform in the future. Although Abbott Laboratories investors may use each financial statement separately, they are all related. The changes in Abbott Laboratories's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Abbott Laboratories's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Abbott Laboratories Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Abbott Laboratories. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue442.8 M420.7 M
Total Revenue40.1 B22.2 B
Cost Of Revenue18 B9.6 B
Stock Based Compensation To Revenue 0.02  0.01 
Sales General And Administrative To Revenue 0.29  0.22 
Research And Ddevelopement To Revenue 0.07  0.1 
Capex To Revenue(0.05)(0.06)
Revenue Per Share 23.05  24.20 
Ebit Per Revenue 0.16  0.21 

Abbott Laboratories Investors Sentiment

The influence of Abbott Laboratories' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Abbott. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Abbott Laboratories' public news can be used to forecast risks associated with an investment in Abbott. The trend in average sentiment can be used to explain how an investor holding Abbott can time the market purely based on public headlines and social activities around Abbott Laboratories. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Abbott Laboratories' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Abbott Laboratories' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Abbott Laboratories' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Abbott Laboratories.

Abbott Laboratories Implied Volatility

    
  89.57  
Abbott Laboratories' implied volatility exposes the market's sentiment of Abbott Laboratories stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abbott Laboratories' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abbott Laboratories stock will not fluctuate a lot when Abbott Laboratories' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Abbott Laboratories in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Abbott Laboratories' short interest history, or implied volatility extrapolated from Abbott Laboratories options trading.

Pair Trading with Abbott Laboratories

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Abbott Laboratories position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abbott Laboratories will appreciate offsetting losses from the drop in the long position's value.

Moving against Abbott Stock

  0.44WST West Pharmaceutical Earnings Call This WeekPairCorr
The ability to find closely correlated positions to Abbott Laboratories could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Abbott Laboratories when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Abbott Laboratories - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Abbott Laboratories to buy it.
The correlation of Abbott Laboratories is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Abbott Laboratories moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Abbott Laboratories moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Abbott Laboratories can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Abbott Laboratories is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Abbott Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Abbott Laboratories Stock. Highlighted below are key reports to facilitate an investment decision about Abbott Laboratories Stock:
Check out the analysis of Abbott Laboratories Correlation against competitors.
For more information on how to buy Abbott Stock please use our How to Invest in Abbott Laboratories guide.
Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.55
Dividend Share
2.08
Earnings Share
3.27
Revenue Per Share
23.051
Quarterly Revenue Growth
0.015
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abbott Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.